TNXP - Tonix Pharmaceuticals Holding Corp.


13.45
-0.270   -2.007%

Share volume: 279,479
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.14%

PREVIOUS CLOSE
CHG
CHG%

$13.72
-0.27
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 03-31-2024 06-30-2024 09-30-2024 12-31-2024 03-31-2025 06-30-2025 09-30-2025
Fiscal Quarter Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Report Date 05-13-2024 08-16-2024 11-12-2024 03-18-2025 05-12-2025 08-11-2025 11-10-2025
Total revenue 2.482 M 2.208 M 2.822 M 2.582 M 2.429 M 1.998 M 3.290 M
Cost of revenue 1.660 M 3.367 M 1.555 M 1.183 M 943.000 K 3.272 M 1.367 M
Gross profit 822.000 K -1.159 M 1.267 M 1.399 M 1.486 M -1.274 M 1.923 M
    -241.00% 209.32% 10.42% 6.22% -185.73% 250.94%  
Operating expenses 22.173 M 17.200 M 16.821 M 23.879 M 17.540 M 27.022 M 34.990 M
Selling general and admin 9.310 M 7.502 M 7.707 M 15.582 M 10.104 M 16.202 M 25.701 M
Research and development 12.863 M 9.698 M 9.114 M 8.297 M 7.436 M 10.820 M 9.289 M
Total expenses 22.173 M 76.157 M 16.821 M 23.879 M 17.540 M 27.022 M 34.990 M
    243.47% -77.91% 41.96% -26.55% 54.06% 29.49%  
Operating income -21.351 M -77.316 M -15.554 M -22.480 M -16.054 M -28.296 M -33.067 M
Ebit -14.346 M -78.171 M -15.881 M -24.232 M -15.660 M -30.251 M -34.223 M
Pretax income -14.346 M -78.171 M -15.881 M -24.232 M -17.752 M -29.308 M -32.992 M
    444.90% -79.68% 52.58% -26.74% 65.10% 12.57%  
Income tax 0.000 0.000 -1.668 M 0.000 -923.000 K -1.036 M -982.000 K
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income -14.939 M -78.776 M -14.213 M -22.108 M -16.829 M -28.272 M -32.010 M
    -427.32% 81.96% -55.55% 23.88% -68.00% -13.22%